Axi Patel, MD (@DoctorAxi) profile picture

Rheumatologist | Assistant Professor | University of Illinois, Chicago Cofounder @alwaysraas @officialgyfr

Chicago, IL
Joined March 2020
Photo by Axi Patel, MD (@DoctorAxi)Photo by Axi Patel, MD (@DoctorAxi)Photo by Axi Patel, MD (@DoctorAxi)Photo by Axi Patel, MD (@DoctorAxi)Photo by Axi Patel, MD (@DoctorAxi)Photo by Axi Patel, MD (@DoctorAxi)Photo by Axi Patel, MD (@DoctorAxi)Photo by Axi Patel, MD (@DoctorAxi)Photo by Axi Patel, MD (@DoctorAxi)Photo by Axi Patel, MD (@DoctorAxi)
2026 FDA approvals in rheum, presented by Dr. Jeong Min Yu (FDA) at #ACR26: Brepocitinib: adult DM (JAK/TYK2) Tildrakizumab: adult PsA Anifrolumab SC: SLE Guselkumab: slows structural damage in PsA Peds: secukinumab AS ≥12 y, risankizumab PsA ≥6 y #ACRambassador
1
3
176
New FDA safety label changes to know: JAKi: hypoglycemia in diabetes Tofacitinib: PML, fractures Belimumab: SJS/TEN Bisphosphonates: atypical non-femoral fractures Oral MTX: deaths from daily-dosing errors Dr. Karmela Kim Chan (FDA) #ACR26 #ACRambassador
1
3
98
A round of applause for the new ACR President Anne Bass, MD! Dr. Bass anointed her term by adjourning the ACR Business Meeting this afternoon. She received a standing ovation 👏 #ACR26
4
2
19
2,541
Which AI tool can you trust for rheum questions? 5 platforms vs 60 ACR/EULAR-based scenarios Guideline concordance: 75–91% Hallucinations: 3.8–18.1% 0 of 5 error-free (dosing, outdated tx, screening) AI output = a draft, not a decision @ACRheum #ACR26 #ACRambassador Ab#0869
3
2
281
And the #ACR26 Knowledge Bowls winners are... the CAR-Titans from KIMS Hospitals, who rose to the occasion and successfully defended their 2025 title! 🏆 Congratulations to the team on your second Knowledge Bowl victory. Think you can take them on in 2027? Start training now! 🧠 #Rheumatology #KnowledgeBowl
5
20
1
73
2,439
⚖️ #ACR26 plenary (McCormick et al., RISE registry): in RA/PsA patients starting semaglutide or tirzepatide, each 5% weight loss was linked to better RAPID3 and 14% higher odds of meaningful gain. Mean loss 6.9% at 12 mo. @ACRheum #ACRambassador
1
3
210
Great to see ACR and OpenEvidence teaming up to put trusted patient education resources in clinicians' hands. 👏 #ACR26 @ACRheum #ACRambassador
📰 Newsflash! Yesterday during the ACR Convergence Opening Session, ACR President William Harvey, MD, MSc, FACR, announced a new collaboration between the ACR and OpenEvidence. This relationship aims to strengthen the connection between evidence-based information, patient education, and informed participation in care by giving rheumatologists, primary care providers, and other specialists managing rheumatic conditions the ability to access trusted, evidence-based ACR patient education resources through OpenEvidence. Read more → acr.tw/4j5nRNq
2
60
Dermatomyositis at the #ACR26 Year in Review (Dr. Liana Fraenkel): brepocitinib (oral TYK2/JAK1) is now FDA approved. At 30 mg, 54% reached moderate response on ≤2.5 mg prednisone vs 27% placebo. Mind the boxed infection warning and JAK precautions. @ACRheum #ACRambassador
2
135
Have you tried Ask ACR yet? Our new virtual assistant is here to help with any and all questions about ACR Convergence and is now available on any ACR Convergence page on rheumatology.org! Check it out → rheumatology.org/ask-acr #ACR26
3
4
639
Over the next several days, #ACR26 participants from around the world will delve into recent breakthroughs in the foundational science and clinical care of rheumatology, as well as new developments in medical education and more. Read the exciting details in ACR Convergence Today → acr.tw/4BKmJ9v
6
1
7
821
Excited to be joining the #ACR26 Social Media Ambassador team! Looking forward to bringing you the latest from ACR Convergence 2026 #ACRambassador
Meet the ACR Social Media Ambassadors! Follow along as these rheumatology social media stars get ready for ACR Convergence 2026. Discover their must-see sessions, join them at the meeting experience, and get a first-hand look at what the #rheum community is all about! Find and follow them here → rheumatology.org/social-medi… #ACR26 #ACRambassador
1
2
145
🆕 Secrets & Pearls of Rheumatology at #ACR25 | Part 1 by @Janetbirdope 🖐️ Cutaneous Pathology SLE/DM 🧴 Tips for SLE  💪 Cancer Screening in Myositis 🩸 Laboratory Testing 🥶 Raynaud's / Scleroderma 👀 Sjogrens Disease #RheumX  #Lupus #Myositis  #Scleroderma #Sjogrens
2
60
2
205
14,315
Panelists will examine how to best deliver rheumatology care in the face of workforce challenges during an #ACR25 session. 🔗 Learn more → acr.tw/4np2o0Y
2
3
559
⚠️ Drug–Drug Interactions Alert! And renal remarks! 💊 Key warnings: Tizanidine + CYP1A2 inhibitors ❌ Avoid Voclosporin + CYP3A inhibitors ❌ Avoid Tofacitinib/CyA/Tacrolimus + CYP3A inhibitors → ⚙️ Adjust 🕵🏻‍♀️vigilance prevents toxicity! #ACR25 #ACR25ambassador @ACRheum
1
5
370
HCQ levels matter more than the dose. Let’s individualize, not generalize! #ACR25 #ACRambassador @ACRheum
Plenary 3, HCQ blood levels in SLE HCQ level > 1150: 1.9x risk of HCQ toxicity HCQ level < 750: 1.4x risk of active SLE HCQ dose < 5mg/kg: 1.9x risk active SLE My take home? Blindly reducing dose to <5mg/kg is BAD; use levels instead! @RheumNow #ACRBest #ACR25 Abstr1722
1
260
🩺 Empowering Patients Through Health Literacy • Poor literacy fuels fear & misinformation • Education builds trust & better outcomes • Meet patients where they are • Stories > stats: narratives change beliefs • Clinicians online can counter myths #ACR25 #ACRambassador
1
6
380
And the winner is...CAR-Titans @kimshospitals! Congratulations on dominating the #ACR25 #ACRKnowledgeBowl this year + taking home the Team Spirit Award too! 🏆📣🎉
1
11
1
38
3,816
The exciting final round of the #ACRKnowledgeBowl takes place TODAY at 1:00 PM CT in W375C! #ACR25 in-person attendees—join us to see which team will be crowned the 2025 ACR Knowledge Bowl Champion. 🏆 🏆 🏆 Will it be Metrotrexate @metrohealthCLE, CAR-Titans @kimshospitals, Stiff Competition @UMNews, or The ANCA-Teers @GeisingerHealth? 🤔Don’t miss it!
1
8
754
Axi Patel, MD retweeted
Journal Club with the editors of A&R and ARD at #ACR25 📅 Today! Monday, Oct 27, 1:00-2:00 PM, Room W185A-D Hear from Dr. Lakin about her recent study published in A&R: 👉 Skin Biopsies Enhance Prediction of Clinical Trajectory in Diffuse Cutaneous Systemic Sclerosis
8
16
1,663
⭐ #ACR25 poster spotlight: Allyson Covello, MD, shares insight into the poster Patient Portal Awareness and Utilization Across Diverse Rheumatology Populations. 🔗 Learn more → acr.tw/43xwsAl
1
1
462